{"product_id":"ret4trutide-20mg","title":"Ret4trutide 20Mg","description":"\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eRETATRUTIDE — Advanced Triple Receptor Agonist for Metabolic Research\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eInvestigational Peptide | GLP-1, GIP \u0026amp; Glucagon Receptor Agonist | Obesity \u0026amp; Metabolic Research\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eProduct Overview\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eRetatrutide is an innovative investigational peptide developed by Eli Lilly that simultaneously targets three metabolic hormone receptors: GLP-1, GIP, and glucagon.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis triple receptor agonist is being investigated for its potential in obesity management, type 2 diabetes, and metabolic regulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eBy activating multiple hormonal pathways involved in appetite control, glucose metabolism, and energy expenditure, retatrutide represents an emerging approach to metabolic research.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eMechanism of Action\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eRetatrutide combines three complementary mechanisms:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGLP-1 Receptor Activation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Influences appetite regulation, increases satiety, and supports glucose-dependent insulin secretion.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGIP Receptor Activation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Contributes to glucose regulation and metabolic signaling.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGlucagon Receptor Activation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Influences hepatic energy metabolism and may contribute to increased energy expenditure.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eMetabolic Homeostasis:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e The combined activation of these receptors is being investigated for its effects on body weight, glucose control, and energy balance.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eClinical Research \u0026amp; Findings\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eClinical investigations have reported substantial weight reduction in selected study populations.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn a Phase II trial, participants receiving the highest studied dose achieved an \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eaverage body weight reduction of up to 24.2% over 48 weeks\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThese findings have supported further investigation through advanced Phase III clinical trials.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eHowever, trial results should not be interpreted as guaranteed individual outcomes or definitive proof of superiority over all currently available weight-management treatments.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003ePotential Research Applications\u003c\/span\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eObesity Research:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Investigation of metabolic and hormonal pathways involved in body weight regulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eType 2 Diabetes Research:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Evaluation of glucose homeostasis and insulin-related metabolic responses.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eEnergy Expenditure:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Exploration of metabolic processes associated with energy utilization.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eAppetite Regulation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Research into hormonal mechanisms affecting hunger and satiety.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eMetabolic Health:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Investigation of obesity-related metabolic complications.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eDevelopment Status \u0026amp; Safety\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eRetatrutide remains an investigational pharmaceutical compound undergoing advanced clinical development, including Phase III trials.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIt is not approved for routine clinical use.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eReported adverse events in clinical studies have commonly included gastrointestinal symptoms such as nausea, vomiting, and diarrhea.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eFurther research is required to fully establish its long-term safety, effectiveness, and benefit-risk profile across different patient populations.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eResearch Use Only\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eFOR AUTHORIZED SCIENTIFIC AND CLINICAL RESEARCH PURPOSES ONLY.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIntended exclusively for qualified professionals conducting legitimate scientific investigations and appropriately authorized clinical research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eNot approved for general human or veterinary use. Not intended for personal injection, self-administration, or unsupervised therapeutic applications.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eResearch-use labeling does not replace applicable regulatory authorization requirements.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003chr\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePEPTITAN — PRECISION. SCIENCE. RESEARCH.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":59501988249864,"sku":null,"price":300.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1078\/2942\/8488\/files\/Frasco_de_Vidro_com_Arcos_Dourados.png?v=1794657660","url":"https:\/\/peptgrind.com\/products\/ret4trutide-20mg","provider":"peptitan","version":"1.0","type":"link"}